Etomidate and ketamine are frequently used for RSI in critically ill patients. Recent articles have raised concern about an increased incidence of post-intubation hypotension in patients who receive ketamine for RSI. Notwithstanding, is either agent superior for RSI in the critically ill? In this podcast we discuss the recently published EvK trial, which evaluated etomidate and ketamine for RSI in emergency endotracheal intubations.
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure. While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation...
Acute respiratory failure (ARF) is a leading cause of ICU admission, intubation, and initiating mechanical ventilation. Noninvasive respiratory support is a critical therapy used...
Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA. PARAMEDIC2 was just published and is the largest randomized...